MetaCap

Cytokinetics Statistics

NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

50.78-0.68 (-1.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cytokinetics by the numbers

Cytokinetics has a market capitalization of $7.07 billion based on 139.30M shares outstanding. With trailing EPS of $-6.02, Cytokinetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.9% below its 50-day average and 26.9% below its 200-day average.

Average daily trading volume is 2.02M shares, or about $102.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CYTK valuation vs. peer median

CYTK compared with the median of 8 peer companies
MetricCYTKPeer medianDifference
Market cap$7.07B$7.37B-4%
Avg. volume2.02M1.18M+71%

Peer median across 8 companies: AMRX, CORT, KNSA, AXSM, ALKS, RYTM, PTGX, ABVX.

Valuation

Price / sales (latest FY)
80.35
EPS (TTM)
$-6.02

Price and trading

Previous close
51.46
Open
51.23
Day range
50.60 – 53.38
52-week range
50.32 – 88.31
52-week change
-22.40%
Beta
—
Volume
1.43M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
7.07B
Forward Pe
-12.03
Eps
-6.02
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
88.31
Week52 Low
50.32
Avg Volume
2.02M
Shares Outstanding
139.30M
Ma50
61.89
Ma200
69.49
Earnings Date
Nov 4, 2026
Pct From52w High
-42.50%
Pct From52w Low
0.91%

Related